In vitro diagnostics manufacturer across hemostasis, acute care, and transplant
Werfen operates a global diagnostics business (€2.2B revenue, 7,000 employees) with five specialized product lines and direct presence in 30 countries. The tech stack is enterprise-heavy (SAP, Salesforce, ServiceNow) with emerging data analytics (dbt, Python, Pandas, Power BI), but hiring momentum is sales and support-focused—nearly 2/3 of active roles are customer-facing—while engineering and data teams remain lean, signaling either post-platform stability or a gap in engineering capacity relative to growth.
Werfen manufactures in vitro diagnostic instruments and reagents for hospital and laboratory settings, specializing in hemostasis testing, acute care diagnostics, transfusion, autoimmunity, and transplant monitoring. Founded in 1966 in Barcelona, the company operates through 30 country offices and 100+ distributor partnerships. The workforce spans R&D, manufacturing, clinical affairs, and commercial functions. Active projects include instrument go-live processes, clinical studies, customer data consolidation, and transfusion technology strategy—reflecting the operational cadence of a regulated, multi-product diagnostics firm scaling globally.
Worldwide sales in 2024 were approximately €2.2 billion, making Werfen one of the larger independent diagnostics manufacturers by revenue.
Werfen actively recruits across 13 countries: United States, Mexico, Germany, Bulgaria, Spain, Italy, Saudi Arabia, Netherlands, Uruguay, Hungary, Colombia, Thailand, and Czechia.
Werfen's core enterprise stack includes SAP (ECC, S/4HANA, GRC, Access Control), Salesforce, ServiceNow, and Manhattan. Data analytics uses dbt, Python, Pandas, Power BI, and Qlik. Infrastructure includes AWS, Fortinet, and CyberArk.
Other companies in the same industry, closest in size